Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

News
Cortical Thinning May Begin After Psychosis Onset in Patients With Schizophrenia
06/16/2022
In people with schizophrenia, cortical thickness appears to be unaltered at the onset of psychosis but to grow thinner throughout the illness course.
In people with schizophrenia, cortical thickness appears to be unaltered at the onset of psychosis but to grow thinner throughout the illness course.
In people with schizophrenia,...
06/16/2022
Psych Congress Network
News
Better Sleep Habits Linked With Reduced Hazardous Drinking
06/16/2022
Better sleep habits indirectly reduced hazardous drinking among adults between the ages of 21 and 29, and reduced drinking was linked with improved sleep, according to a Penn State University study.
Better sleep habits indirectly reduced hazardous drinking among adults between the ages of 21 and 29, and reduced drinking was linked with improved sleep, according to a Penn State University study.
Better sleep habits indirectly...
06/16/2022
Psych Congress Network

Advertisement

News
ADHD Medication Linked With Lower Unemployment Risk, Particularly In Women
06/14/2022
Pharmacological treatment for ADHD was associated with a lower risk of long-term unemployment, especially in women, in a population-based cohort study in Sweden.
Pharmacological treatment for ADHD was associated with a lower risk of long-term unemployment, especially in women, in a population-based cohort study in Sweden.
Pharmacological treatment for...
06/14/2022
Psych Congress Network
News
Access to Medical Marijuana Improved Insomnia, but No Change to Pain, Anxiety
06/14/2022
Patients granted immediate access to medical marijuana exhibited improved self-reported sleep quality and mental well-being, but also displayed higher incidence and severity of cannabis use disorder (CUD), new research says.
Patients granted immediate access to medical marijuana exhibited improved self-reported sleep quality and mental well-being, but also displayed higher incidence and severity of cannabis use disorder (CUD), new research says.
Patients granted immediate...
06/14/2022
Neurology
News
Major Depressive Disorder Trials Lack Complete PRO Reporting, Analysis Finds
06/13/2022
Patient-reported outcomes (PROs) for major depressive disorder were inconsistently reported across dozens of randomized controlled trials, according to a study published in the Journal of Psychiatric Research.
Patient-reported outcomes (PROs) for major depressive disorder were inconsistently reported across dozens of randomized controlled trials, according to a study published in the Journal of Psychiatric Research.
Patient-reported outcomes (PROs)...
06/13/2022
Psych Congress Network

Advertisement

News
Dementia Risk Screening Should Include Dual Gait Speed Alongside Memory Assessment
06/13/2022
Clinicians should include gait speed in dementia risk screening assessments, according to a cohort study published in Jama Network Open.
Clinicians should include gait speed in dementia risk screening assessments, according to a cohort study published in Jama Network Open.
Clinicians should include gait...
06/13/2022
Psych Congress Network
News
Heightened Risk of AUD Linked With Binge Consumption in Moderate Drinkers
06/09/2022
Moderate average drinkers with a pattern of engaging in binge drinking were found to be almost 5 times more likely to experience multiple alcohol-related problems, compared with individuals who drink the same amount overall but don’t binge.
Moderate average drinkers with a pattern of engaging in binge drinking were found to be almost 5 times more likely to experience multiple alcohol-related problems, compared with individuals who drink the same amount overall but don’t binge.
Moderate average drinkers with a...
06/09/2022
Psych Congress Network
News
Pandemic-Related Buprenorphine Prescribing Changes Linked With Improved Outcomes
06/08/2022
COVID-19-related changes to buprenorphine prescribing guidelines improved opioid use disorder patient outcomes, according to Drexel University researchers.
COVID-19-related changes to buprenorphine prescribing guidelines improved opioid use disorder patient outcomes, according to Drexel University researchers.
COVID-19-related changes to...
06/08/2022
Psych Congress Network

Advertisement

News
TMS Guided by EEG Eases Major Depression in Half the Session Time
06/07/2022
TMS guided by electroencephalography (EEG) is safe, effective, and associated with substantially shorter treatment times than standard left frontal TMS in patients with depression and anxiety disorders.
TMS guided by electroencephalography (EEG) is safe, effective, and associated with substantially shorter treatment times than standard left frontal TMS in patients with depression and anxiety disorders.
TMS guided by...
06/07/2022
Psych Congress Network
News
Mentalizing Imagery Therapy Improves Depression, Well-Being in Dementia Caregivers
06/07/2022
Mentalizing imagery therapy was superior to a support group for easing depression and anxiety, and improving mindfulness, self-compassion, and well-being, in family caregivers of patients with dementia.
Mentalizing imagery therapy was superior to a support group for easing depression and anxiety, and improving mindfulness, self-compassion, and well-being, in family caregivers of patients with dementia.
Mentalizing imagery therapy was...
06/07/2022
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use